Latest News and Press Releases
Want to stay updated on the latest news?
-
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2024 En application de l'article L. 233-8 II du code de commerce et de l'article...
-
Chicago, July 23, 2024 (GLOBE NEWSWIRE) -- The "Contrast Media Injectors Market Size, Share & by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single &...
-
New Delhi, July 15, 2024 (GLOBE NEWSWIRE) -- The global contrast media market generated revenue of US$ 5,492.7 million in 2023 and is projected to reach US$ 7,750.4 million by 2032 at a CAGR of 3.9%...
-
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Global MRI Contrast Media Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global MRI...
-
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5...
-
New York, United States , June 20, 2024 (GLOBE NEWSWIRE) -- The Global MRI Contrast Media Market Size is to Grow from USD 1.50 Billion in 2023 to USD 2.35 Billion by 2033, at a Compound Annual...
-
Hugues Lecat appointed Chairman of the Board of Directors of Guerbet Villepinte, 24 May 2024: Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging,...
-
Hugues Lecat nommé Président du Conseil d’administration de Guerbet Villepinte, le 24 mai 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie...
-
NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics -- Agreement brings together Guerbet’s industry leading expertise in medical...
-
COMMUNIQUE DE PRESSE NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre L'accord allie...